CLOV

CLOV

USD

Clover Health Investments Corp. Class A Common Stock

$3.340+0.010 (0.300%)

リアルタイム価格

Healthcare
Healthcare Plans
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$3.330

高値

$3.400

安値

$3.254

出来高

0.44M

企業ファンダメンタルズ

時価総額

1.7B

業種

Healthcare Plans

United States

取引統計

平均出来高

5.63M

取引所

NMS

通貨

USD

52週レンジ

安値 $0.693現在値 $3.340高値 $4.87

AI分析レポート

最終更新: 2025年5月3日
AIによる生成データソース: Yahoo Finance, Bloomberg, SEC

CLOV: Clover Health Investments Corp. Class A Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: CLOV Generate Date: 2025-05-03 20:26:19

Alright, let's break down what's been going on with Clover Health stock (CLOV) based on the latest information. We'll look at the recent news, check out what the price has been doing, and see what the AI crystal ball is hinting at.

Recent News Buzz - What's the Vibe?

Looking at the news headlines from the past couple of weeks, things seem to lean pretty positive for Clover Health.

First off, there's news about their subsidiary, Counterpart Health, and how using their tech with primary care doctors is linked to better results for patients dealing with congestive heart failure. That's a good sign, suggesting their technology platform, the Clover Assistant, is actually making a difference in patient care.

Then, there's a broader piece talking about how AI in healthcare could unlock billions in market value. This is relevant because Clover Health specifically uses AI through its Clover Assistant platform to help doctors. So, if the AI trend in healthcare is big, Clover is positioned right in the middle of it.

We also saw news about changes to the company's Board of Directors and plans to participate in upcoming investor conferences. Board changes are often just standard corporate stuff, not necessarily good or bad on their own. But going to investor conferences? That usually means the company is actively talking to potential investors, which is generally seen as a positive step.

So, putting it together, the recent news flow feels constructive. It highlights the potential benefits of their core technology and shows the company is engaging with the financial community.

Price Check - What's the Stock Been Doing?

Now, let's look at the stock price itself over the last couple of months. If you glance at the historical data, you'll see that after trading in the $4 range back in February, the price started a noticeable slide through March. It hit lows around the mid-$3 mark.

In April, the price seemed to find a bit of a floor, mostly bouncing around between $3.40 and $3.70, though there was one sharp dip below $3 briefly. More recently, in the last few days of April and early May, the stock has been trading pretty tightly, hovering right around the $3.30 to $3.40 level. The previous day's close was $3.32.

What about the AI's prediction for the very near future? The AI model suggests the price will stay flat today (0.00% change), but then tick up slightly over the next two days, predicting a 1.06% rise tomorrow and a 1.78% rise the day after. This suggests the AI sees a small upward move coming from the current price point.

Outlook & Strategy Ideas - Putting It All Together

So, what does this mix of news, price action, and AI prediction suggest?

The positive news about their tech and the broader AI trend in healthcare provides a potentially favorable backdrop. The price has been weak overall but seems to have settled into a recent range, and the AI is forecasting a modest bounce from here.

Based on this, the current situation might lean towards a 'hold' or perhaps a cautious 'accumulate' stance for those interested in the stock. The price is near the lower end of its recent trading range and close to a potential support level mentioned in the recommendation data ($3.35).

If you were considering getting involved, a potential entry area could be around the current price level, say between $3.30 and $3.40. This aligns with where the stock has been trading recently and where the AI predicts a slight upward move starting.

Thinking about managing risk, the recommendation data suggests a potential stop-loss level around $3.00. This is below the recent trading range and offers some room before cutting losses if the price were to fall further. For taking profits, the recommendation points to $3.40, which is right at the top of the recent tight trading range and aligns somewhat with the AI's short-term upward forecast. It could be a potential near-term target to watch.

Company Context

Just remember, Clover Health is primarily focused on Medicare Advantage plans and uses its technology platform, Clover Assistant, as a key part of its strategy. So, news related to healthcare tech, AI in medicine, and government programs like Medicare are particularly important to watch for this company.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

関連ニュース

GlobeNewswire

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") and

もっと見る
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
PR Newswire

New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down...

もっと見る
New Advances in Healthcare AI Could Unlock Billions in Market Opportunity
GlobeNewswire

Clover Health Announces Changes to Board of Directors

WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that after four years of distinguished service, Lee A.

もっと見る
Clover Health Announces Changes to Board of Directors
GlobeNewswire

Clover Health to Participate in Upcoming Investor Conferences

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced its participation in the following investor conferences:

もっと見る
Clover Health to Participate in Upcoming Investor Conferences

AI予測Beta

AI推奨

強気

更新日時: 2025年5月4日 07:06

弱気中立強気

61.9% 信頼度

リスクと取引

リスクレベル3/5
中リスク
適しているのは
バリューアグレッシブ
取引ガイド

エントリーポイント

$3.34

利確

$3.40

損切り

$3.00

主要因子

DMIは弱気トレンドを示しており (ADX:13.6、+DI:6.1、-DI:9.1)、注意が必要です
現在の価格はサポートレベル(3.35ドル)に非常に接近しており、強力な買い機会を示唆しています
出来高は平均(66,122)の5.4倍で、極めて強い買い圧力を示しています
MACD -0.0017はシグナルライン0.0016の下にあり、弱気クロスオーバーを示しています

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。